Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study

BACKGROUND: There is lack of consensus whether neoadjuvant chemoradiotherapy (CHT/RT) is superior to neoadjuvant chemotherapy (CHT) alone in patients with potentially resectable stage III/N2 non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS: We retrospectively evaluated clinical parameters an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinn, K., Mosleh, B., Steindl, A., Zoechbauer-Mueller, S., Dieckmann, K., Widder, J., Steiner, E., Klepetko, W., Hoetzenecker, K., Laszlo, V., Doeme, B., Klikovits, T., Hoda, M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058885/
https://www.ncbi.nlm.nih.gov/pubmed/35397435
http://dx.doi.org/10.1016/j.esmoop.2022.100466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058885/
https://www.ncbi.nlm.nih.gov/pubmed/35397435
http://dx.doi.org/10.1016/j.esmoop.2022.100466

Ejemplares similares